EN | TR
E-ISSN: 2147-1894
A Novel Minimally Invasive Treatment Option for Benign Prostat Hyperplasia: Intraprostatic UroLift<sup>®</sup>, The First Case Series of Turkey with Short Term Follow-up
PDF
Cite
Share
Request
Original Investigation
VOLUME: 3 ISSUE: 2
P: 74-78
August 2013

A Novel Minimally Invasive Treatment Option for Benign Prostat Hyperplasia: Intraprostatic UroLift®, The First Case Series of Turkey with Short Term Follow-up

J Acad Res Med 2013;3(2):74-78
DOI: 10.5152/jarem.2013.19
Yiğit Akın 1
Aliseydi Bozkurt 1
Muzaffer Oğuz Keleş 2
Hakan Gülmez 3
Murat Şahin 4
Barış Nuhoğlu 1
1. Erzincan Üniversitesi Tıp Fakültesi, Üroloji Anabilim Dalı, Erzincan, Türkiye
2. Mengücek Gazi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Erzincan, Türkiye
3. Başkent Üniversitesi Tıp Fakültesi, Aile Hekimliği Anabilim Dalı, Ankara, Türkiye
4. Erzincan Üniversitesi Tıp Fakültesi, Anestezi Anabilim Dalı, Erzincan, Türkiye
No information available.
No information available
Received Date: 05.05.2013
Accepted Date: 24.06.2013
PDF
Cite
Share
Request

ABSTRACT

Objective:

To evaluate feasiblity, effectiveness, applicable of UroLift® which is a minimally invasive surgical treatment option in patients with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).

Methods:

Between March 2011 and May 2013, data of patients who were operated with UroLift®, were investigated retrospectively. There were totally 10 patients. Demographic data of patients and internationale prostate symptom score (IPSS), quality of life (QoL) index, internationale index of erectile function (IIEF), uroflowmetry (UFM) parameters were recorded before operation. Additionally, operation data, postoperative data and short follow-up were recorded and evaluated. In statistical analysis, statistical p value was accepted as p<0.05.

Results:

Mean age was 64.8±10 years, and 10 men evaluated totally. After 1 month and 3 months UroLift® implantation, in short follow-up, maximum (respectively; p<0.001, p<0.001) and mean urine flow rate statistical significant increased (respectively; p<0.001, p<0.001). Additionally post mictional residuel volume in bladder statistical significantly decreased (respectively; p=0.025, p=0.016). There was statistically significant decrease in IPSS after 1st and 3rd months of surgery (respectively, p<0.001, p<0.001). Development in QoL index were parallel to develoments in IPSS, after 1 month and 3 months of surgery (respectively; p=0.022, p=0.003). UroLift® was effective in all patients. Additionally, there was no significant difference in IIEF scores in follow-up.

Conclusion:

UroLift® was effevtive in selected patients. In addition, it was new, safe, a novel minimally invasive surgical treatment option in BPH. (JAREM 2013; 3: 74-8)

Keywords: Benign prostat hyperplasia, quality of life, prostate, uroflowmetry, UroLift®

References

2024 ©️ Galenos Publishing House